Concordant oral-genital HPV infection in South Africa couples: Evidence for transmission

Frontiers in Oncology

Volumn 3 DEC, Issue , 2013, Pages

  Vogt, Samantha L ^a   Gravitt, Patti E ^b   Martinson, Neil A ^c,d   Hoffmann, Jennifer ^d   D'Souza, Gypsyamber ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Concordance; Genital; HIV; HPV; Oral; Oral sex; South Africa; Transmission

Indexed keywords

EID: 84892585692     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00303     Document Type: Article

References (35)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 189(1):12-9. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2- F.
2. Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (Vol. 90). Lyon: International Agency for Research on Cancer (2007).
3. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol (2010) 11(8):781-9. doi:10.1016/S1470-2045(10)70017-6.
4. Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev (2012) 21(1):122-33. doi:10.1158/1055-9965.EPI-11-0734.
5. Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison ML. Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 208(2):330-9. doi:10.1093/infdis/jit170.
6. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in South Africa. Summary report. (2010) [cited 2013 May 5]. Available from: http://www.hpvcentre.net/statistics/reports/ZAF.pdf.
7. Global Report: UNAIDS Report on the Global AIDS Epidemic 2012. (2012) [cited 2013 May 5]. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiolo gy/.
8. Abraham AG, Stickler HD, Jing Y, Gange SJ, Sterling TR, Silverberg M, et al. Invasive cervical cancer risk among HIV-infected women: a North American multi-cohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 62(4):405-13. doi:10.1097/QAI.0b013e31828177d7.
9. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 97(6):425-32. doi:10.1093/jnci/dji072.
10. Mqoqi N, Kellet P, Madhoo J, Sitas F. Cancer in South Africa, 1996-1997. Johannesburg: National Cancer Registry of South Africa, National Health Laboratory Service (2003).
11. Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, et al. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer (2009) 9:275. doi:10.1186/1471-2407-9-275.
12. Omar T, Schwartz S, Hanrahan C, Modisenyane T, Tshabangu N, Golub JE, et al. Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS (2011) 25(1):87-94. doi:10.1097/QAD.0b013e328340fd99.
13. Adler DH, Kakinami L, Modisenyane T, Tshabangu N, Mohapi L, De Bruyn G, et al. Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART. AIDS (2012) 26(13):1645-52. doi:10.1097/QAD.0b013e32835536a3.
14. D'Souza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, Minkoff HL, et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 121(1):143-50. doi:10.1002/ijc.22667.
15. Giuliano AR, Lazcano E, Villa LL, Flores R, Salmeron J, Lee JH, et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer (2009) 124(6):1251-7. doi:10.1002/ijc.24097.
16. D'Souza G, Sugar E, Ruby W, Gravitt P, Gillison M. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J Clin Microbiol (2005) 43(11):5526-35. doi:10.1128/JCM.43.11.5526-5535.2005.
17. Gravitt PE, Lacey JV Jr, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev (2001) 10(2):95-100.
18. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol (2005) 6(4):204. doi:10.1016/S1470-2045(05)70086-3.
19. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsaqué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 348(6):518-27. doi:10.1056/NEJMoa021641.
20. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer (2009) 4:8. doi:10.1186/1750-9378-4-8.
21. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol (2003) 157:218-26. doi:10.1093/aje/kwf180.
22. Marais DJ, Passmore JA, Denny L, Sampson C, Allan BR, Williamson AL. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa. J Med Virol (2008) 80(6):953-9. doi:10.1002/jmv.21166.
23. Richter KL, van Rensburg EJ, van Heerden WF, Boy SC. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy. J Oral Pathol Med (2008) 37(9):555-9. doi:10.1111/j.1600-0714.2008.00670.x.
24. Gillison ML, Broutain T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA (2012) 307(7):693-703. doi:10.1001/jama.2012.101.
25. Allan B, Marais DJ, Hoffman M, Shapiro S, Williamson AL. Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies. J Clin Microbiol (2008) 46(2):740-2. doi:10.1128/JCM.01981-07.
26. Jones HE, Allan BR, Van de Wijgert JH, Altini L, Taylor SM, de Kock A, et al. Agreement between self-and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa. J Clin Microbiol (2007) 45(6):1679-83. doi:10.1128/JCM.02369-06.
27. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol (2003) 71(2):265-73. doi:10.1002/jmv.10479.
28. Pegoraro RJ, Rom L, Lanning PA, Moodley M, Naiker S, Moodley J. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women. Int J Gynecol Cancer (2002) 12(4):383-8. doi:10.1046/j.1525-1438.2002.01109.x.
29. Williamson AL, Brink NS, Dehaeck CM, Ovens S, Soeters R, Rybicki EP. Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town. J Med Virol (1994) 43(3):231-7. doi:10.1002/jmv.1890430307.
30. Auvert B, Sobngwi-Tambekou J, Cutler E, Nieuwoudt M, Lissouba P, Puren A, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis (2009) 199(1):14-9. doi:10.1086/595566.
31. Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis (2009) 199(10):1514-24. doi:10.1086/598220.
32. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis (2004) 189(4):686-98. doi:10.1086/381504.
33. Rintala M, Grénman S, Puranen M, Syrjänen S. Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV Family Study. J Clin Virol (2006) 35(1):89-94. doi:10.1016/j.jcv.2005.05.012.
34. Fakhry C, D'Souza G, Sugar E, Weber K, Goshu E, Minkoff H, et al. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and-negative women. J Clin Microbiol (2006) 44(12):4479-85. doi:10.1128/JCM.01321-06.
35. Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One (2013) 8(7):e68329. doi:10.1371/journal.pone.0068329.